Current Ratio
since 2005
Calculation
Edwards Lifesciences Corp., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2021 | 3.08 | = | 3,180,700) | ÷ | 1,032,300) |
| Dec 31, 2020 | 3.46 | = | 3,091,000) | ÷ | 893,900) |
| Dec 31, 2019 | 3.31 | = | 2,984,000) | ÷ | 902,400) |
| Dec 31, 2018 | 2.61 | = | 2,286,900) | ÷ | 876,600) |
| Dec 31, 2017 | 1.80 | = | 2,532,100) | ÷ | 1,402,900) |
| Dec 31, 2016 | 4.21 | = | 2,240,000) | ÷ | 532,500) |
| Dec 31, 2015 | 4.30 | = | 2,047,900) | ÷ | 476,200) |
| Dec 31, 2014 | 5.28 | = | 2,294,600) | ÷ | 434,400) |
| Dec 31, 2013 | 4.99 | = | 1,725,800) | ÷ | 345,600) |
| Dec 31, 2012 | 3.72 | = | 1,291,900) | ÷ | 347,400) |
| Dec 31, 2011 | 3.49 | = | 1,168,500) | ÷ | 335,200) |
| Dec 31, 2010 | 3.06 | = | 1,032,600) | ÷ | 337,800) |
| Dec 31, 2009 | 3.06 | = | 889,200) | ÷ | 290,500) |
| Dec 31, 2008 | 2.68 | = | 691,900) | ÷ | 258,500) |
| Dec 31, 2007 | 1.55 | = | 581,700) | ÷ | 375,400) |
| Dec 31, 2006 | 2.35 | = | 531,600) | ÷ | 226,200) |
| Dec 31, 2005 | 2.65 | = | 514,200) | ÷ | 194,200) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Liquidity analysis from 2005 to 2021 reveals a consistent ability to meet short-term obligations, characterized by substantial growth in current assets and periodic volatility in current liabilities.
- Current Asset Expansion
- A sustained upward trajectory is observed in current assets, which grew from 514.2 million US dollars in 2005 to 3.18 billion US dollars by 2021. This growth indicates a significant expansion of the liquid resource base over the analyzed period.
- Current Liability Dynamics
- Current liabilities exhibited more volatility compared to assets. After maintaining a range below 500 million US dollars through 2015, a significant spike occurred in 2017, peaking at 1.4 billion US dollars. Following this peak, liabilities stabilized and fluctuated between 876.6 million and 1.03 billion US dollars from 2018 through 2021.
- Current Ratio Trends and Liquidity Stability
- The current ratio transitioned through three distinct phases. An initial period of contraction occurred between 2005 and 2007, with the ratio falling to 1.55. This was followed by a period of significant liquidity growth between 2008 and 2014, during which the ratio reached a peak of 5.28. A subsequent decline was observed from 2015 to 2017, coinciding with the increase in current liabilities, bringing the ratio down to 1.80. Since 2018, the ratio has recovered and stabilized, maintaining a range between 2.61 and 3.46.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
Edwards Lifesciences Corp., current ratio, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | 3.08 | 1.85 | 1.47 | 5.08 | 2.65 | 0.79 |
| Dec 31, 2020 | 3.46 | 1.72 | 1.55 | 6.86 | 2.13 | 0.74 |
| Dec 31, 2019 | 3.31 | 1.44 | 1.65 | 4.53 | 2.59 | 0.69 |
| Dec 31, 2018 | 2.61 | 1.62 | 1.56 | 5.28 | 2.28 | 0.73 |
| Dec 31, 2017 | 1.80 | 2.26 | 1.55 | 3.99 | 1.75 | 0.73 |
| Dec 31, 2016 | 4.21 | 4.02 | 1.61 | 5.45 | 3.29 | 0.69 |
| Dec 31, 2015 | 4.30 | 1.54 | 1.62 | 4.46 | 3.36 | 0.74 |
| Dec 31, 2014 | 5.28 | 1.45 | 1.72 | 3.69 | 3.82 | 0.77 |
| Dec 31, 2013 | 4.99 | 2.02 | 1.82 | 5.07 | 4.57 | 0.73 |
| Dec 31, 2012 | 3.72 | 2.36 | 1.78 | 4.71 | 1.62 | 0.78 |
| Dec 31, 2011 | 3.49 | 1.54 | 1.71 | 4.57 | 1.93 | 0.85 |
| Dec 31, 2010 | 3.06 | 1.29 | 1.87 | 4.66 | 1.92 | 0.78 |
| Dec 31, 2009 | 3.06 | 1.79 | 1.91 | 4.18 | 2.37 | 0.82 |
| Dec 31, 2008 | 2.68 | 1.47 | 0.81 | 4.28 | 2.07 | 0.76 |
| Dec 31, 2007 | 1.55 | 1.54 | 0.91 | 4.63 | 3.09 | 0.84 |
| Dec 31, 2006 | 2.35 | 0.94 | 0.77 | 4.64 | 2.36 | 0.87 |
| Dec 31, 2005 | 2.65 | 1.54 | 1.75 | 3.60 | 2.20 | 0.64 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., current ratio, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2021 | 3.08 | 1.22 |
| Dec 31, 2020 | 3.46 | 1.19 |
| Dec 31, 2019 | 3.31 | 1.17 |
| Dec 31, 2018 | 2.61 | 1.21 |
| Dec 31, 2017 | 1.80 | 1.24 |
| Dec 31, 2016 | 4.21 | 1.43 |
| Dec 31, 2015 | 4.30 | 1.36 |
| Dec 31, 2014 | 5.28 | 1.43 |
| Dec 31, 2013 | 4.99 | 1.54 |
| Dec 31, 2012 | 3.72 | 1.47 |
| Dec 31, 2011 | 3.49 | 1.36 |
| Dec 31, 2010 | 3.06 | 1.29 |
| Dec 31, 2009 | 3.06 | 1.46 |
| Dec 31, 2008 | 2.68 | 1.04 |
| Dec 31, 2007 | 1.55 | 1.14 |
| Dec 31, 2006 | 2.35 | 0.99 |
| Dec 31, 2005 | 2.65 | 1.31 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., current ratio, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Dec 31, 2021 | 3.08 | 1.31 |
| Dec 31, 2020 | 3.46 | 1.30 |
| Dec 31, 2019 | 3.31 | 1.48 |
| Dec 31, 2018 | 2.61 | 1.52 |
| Dec 31, 2017 | 1.80 | 1.55 |
| Dec 31, 2016 | 4.21 | 1.73 |
| Dec 31, 2015 | 4.30 | 1.70 |
| Dec 31, 2014 | 5.28 | 1.92 |
| Dec 31, 2013 | 4.99 | 1.96 |
| Dec 31, 2012 | 3.72 | 1.84 |
| Dec 31, 2011 | 3.49 | 1.94 |
| Dec 31, 2010 | 3.06 | 1.81 |
| Dec 31, 2009 | 3.06 | 1.78 |
| Dec 31, 2008 | 2.68 | 1.44 |
| Dec 31, 2007 | 1.55 | 1.53 |
| Dec 31, 2006 | 2.35 | 1.39 |
| Dec 31, 2005 | 2.65 | 1.63 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).